PeptideStack
5.2kquestions
20kanswers
220users

What counter-ion should I expect on a KP retatrutide lot?

Asked 12 Dec 2024Modified 15 months agoViewed 46k times
28

Concretely: KP · retatrutide.

I can parse the result. I am less sure what it licenses me to conclude.

I have deliberately not looked at anyone else’s interpretation yet.

What is the correct interpretation, and what is the common misreading?

acetate-content
acetate-content

Counter-ion content, most often acetate or trifluoroacetate, and why it matters: the counter-ion and residual water are part of the gross mass you…

88 questions
purity
purity

Purity as chromatographic area per cent - the fraction of detected material that is your target peak. It says nothing about how much material is…

833 questions
content-assay
content-assay

Quantified content: how many milligrams of peptide are actually in the vial, measured against a calibrated reference standard. A separate test…

476 questions
retatrutide
retatrutide

An investigational GLP-1, GIP and glucagon receptor tri-agonist, studied in the TRIUMPH programme. Not approved anywhere. Use this tag for…

251 questions
shareeditfollowflag
NP
askednet_peptide12k1512 Dec 2024
4Which wavelength was the purity integrated at? Worth adding to the question. – Dr_Idris_Coulibaly 9 months ago
add a comment

5 Answers

Accepted answer first, then by votes
44

Accepted answer

Answer first: the counter-ion is part of the mass you paid for and none of the peptide you wanted, and it can run to several per cent or more.

Net peptide content — the fraction of gross mass that is the peptide itself — is the figure that folds water and counter-ion together and is what you should ask for if you ask for anything.

A supplier who reports both water and counter-ion has given you everything needed to reconcile the vial, and on this site that is a very short list.

Peptides from reverse-phase purification with trifluoroacetic acid mobile phases are isolated as trifluoroacetate salts, which is standard synthesis practice.

Absence of a counter-ion figure is an absent measurement rather than a low one.

Count the basic residues and you can estimate the counter-ion load.

shareimprove this answerflag
TW
answered · acceptedtare_weight60k14818 Jan 2025
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
18

The short version: peptides are supplied as salts, the salt is real mass, and neither purity nor a chromatogram will tell you how much of it there is.

Peptides purified by reverse-phase chromatography with a trifluoroacetic acid mobile phase are isolated as trifluoroacetate salts. The trifluoroacetate content depends on the number of basic residues and can run from a few per cent to well over ten by mass on a heavily basic sequence.

Acetate salts are produced by a deliberate ion exchange after purification. The exchange costs a processing step and is the reason acetate-form material is more expensive.

Counter-ion content scales with the number of basic residues, following directly from charge balance.

Net peptide content varies between lots as the process varies, so one figure does not characterise a supplier.

Water plus counter-ion is why gross mass and peptide mass differ.

shareimprove this answerflag
TQ
answeredtriple_agonist_q57k387 Jan 2025
14

Acetate is generally preferred to trifluoroacetate for biological work, which is why the exchange is done at all.

Quantification differs by ion: trifluoroacetate by ion chromatography or by fluorine nuclear magnetic resonance, acetate by ion chromatography or by capillary electrophoresis. Neither shows up on a UV chromatogram.

In practice, trifluoroacetate has documented biological effects at higher concentrations in cell culture, which is the technical reason acetate exchange exists rather than a marketing one.

Ion chromatography and fluorine NMR are the accepted quantitative methods for trifluoroacetate, and neither is a chromatographic purity method.

The caveat is that a purity figure is completely blind to counter-ion content, and the two are routinely conflated.

Ask for net peptide content. It folds water and counter-ion into one usable number.

shareimprove this answerflag
DV
answereddead_volume56k489 Feb 2025
Adding a vote because this deserves more of them. – e_dziedzic 31 days ago
add a comment
12

A net-peptide-content figure already accounts for it, which is why net content is the number worth asking for.

Worked reconciliation: a 10 mg vial at four per cent water and eight per cent trifluoroacetate contains 10.0 × 0.88 = 8.8 mg of peptide, a twelve per cent shortfall against label with a perfectly clean purity figure.

Nothing here is medical advice, and research-use compounds are not approved for human use.

Trifluoroacetate unless a deliberate exchange was done. Ask which.

shareimprove this answerflag
CL
answeredcold_lane10k1629 Jan 2025
4Which wavelength was the purity integrated at? It changes the number more than people think. – helena_vidmar 8 months ago
5Confirming from the other direction: I ignored the method section once and paid for it. – bac_or_bust 9 months ago
add a comment
11

The relevant arithmetic is that gross mass equals peptide plus counter-ion plus water, and the certificate usually reports only the first indirectly.

The number of basic residues drives counter-ion load, because each protonated basic site pairs with one counter-ion. A sequence with several lysines and arginines carries proportionally more.

Trifluoroacetate effects in cell culture are documented and are the technical basis for salt exchange to acetate.

The caveat is that none of this makes a research-grade vial equivalent to a licensed medicine. There is no release testing programme behind it, no pharmacovigilance, and no recourse if it is wrong. Independent testing narrows your uncertainty; it does not eliminate the category difference.

Purity says nothing about counter-ion. They are unrelated measurements.

edited 16 Apr 2025 by priya_menon — tightened the wording; no substantive change

shareimprove this answerflag
PM
answeredpriya_menon13k354 Apr 2025
8The system-suitability data is the part that tells you whether to believe the rest. – Dr_Wren_Halliday 6 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.